Laboratory testing for Zika virus infection
WHO Interim Guidance 2016 WHO/ZIKV/LAB/16.1.
This interim guidance is for use by staff of laboratories testing for Zika virus infection and for clinical practitioners and public health professionals providing clinical management or surveillance. The guidance is for the current testing strategies of Zika virus infection and the content includes: types of specimens, testing strategies, specimen processing and storage, biosafety, shipping specimens and choosing in vitro diagnostics.
Adolescents, Adults, Both sexes (for groups of both male and female persons), Children, Combatant, Displaced population, Epidemic/Endemic, Health, Healthcare workers, Host population, Infections and infectious diseases (all), Internally displaced population, LGBT (lesbian gay bisexual and transgender), Minorities, Neonates/infants, Nervous system and neurologic conditions, Non-combatant, Older people, Persons with disabilities, Pregnant/lactating women, Prisoners/Detainees, Returning population, Stateless, Viral fevers/VHF, Zoonotic and other pathogens